Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Clinical Research (Excluding Clinical Trials)

Abstract 3793: Discovery and isolation of enormous number of circulating tumor cells in breast cancer patient’s blood based upon cell attachment property

Yeon-a Choi, Hyun Ju Han, Ae-Ran Choi, Jeong Dong Lee, Gun Min Kim, Hyung Seok Park, Seho Park, Seung Il Kim and Joohyuk Sohn
Yeon-a Choi
Yonsei Univ Medical Center, Seoul, Republic of Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyun Ju Han
Yonsei Univ Medical Center, Seoul, Republic of Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ae-Ran Choi
Yonsei Univ Medical Center, Seoul, Republic of Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeong Dong Lee
Yonsei Univ Medical Center, Seoul, Republic of Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gun Min Kim
Yonsei Univ Medical Center, Seoul, Republic of Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyung Seok Park
Yonsei Univ Medical Center, Seoul, Republic of Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seho Park
Yonsei Univ Medical Center, Seoul, Republic of Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seung Il Kim
Yonsei Univ Medical Center, Seoul, Republic of Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joohyuk Sohn
Yonsei Univ Medical Center, Seoul, Republic of Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2017-3793 Published July 2017
  • Article
  • Info & Metrics
Loading
Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC

Abstract

Circulating tumor cells (CTCs) are detached from primary tumors into the bloodstream and known to play a role in tumor metastasis. CTCs are known to be rare, estimated at 1-10 CTCs among 1010 blood cells in a milliliter of blood. Most of existing technologies for CTC enrichment are based on marker expression or size. However, recent studies have suggested that CTCs may have a wide range of marker expression and sizes. The number of CTCs that is isolated from the patient’s blood is fewer than expected. This infrequent and unreliable detection impedes the clinical use of CTCs.

We adopted a concept that presumptive CTC would have differential attachment properties compared to WBC in tissue culture plate because it originated from carcinoma where tumor cells attach each other. To prove the concept, we spiked breast cancer cell lines into 7.5ml of healthy blood. RBC was removed by Ficoll. Diluted peripheral blood mononuclear cells were incubated with 5% CO2 in cell culture incubator for 2h at 37°C. After a thorough rinse with 1×PBS, the plates were treated with 10mM EDTA to detach cells from the bottom. The cells collected were followed by lysis and DNA extraction, or placed on glass slide and stained with anti-CD45, -CK, -HER2, and DAPI. Typically, slides were analyzed by confocal microscope or Metafer slide scanning platform for enumeration of cells. 7.5 mL of peripheral blood was collected from breast cancer patient, and handled as described above.

Our method showed higher detection sensitivities for 6 breast cancer cell lines. We verified that breast cancer cell lines were collected more than 80% of spiked cell number in 2 hours. This technique is applied to isolation of CTCs in actual breast cancer patients, and unexpectedly considerable numbers of CTCs were observed. We found in a range of CTCs from 0.5 × 105 to 1 × 106 per ml of blood. These numbers are in striking contrast to previous studies. CTCs were observed in 61 of 114 samples (53.51%) from metastatic breast cancer patients and 15 of 48 samples (31.25%) from early breast cancer patients. We also discovered that there are various sized CTCs, and categorized these CTCs according to their diameter; small (<5 μM), medium (5-10 μM), and large (>10 μM) CTCs. All three types of CTCs appeared in large numbers. HER2 and EpCAM expression of CTC vary by patients and didn’t always coincide with expression in primary tumor.

In summary, we have developed a promising strategy for CTC isolation by using the preference of cancer cells to adhere to cell culture plates. We have demonstrated that this is a simple yet very efficient approach to isolate CTCs and broadly applicable to capturing heterogeneous CTCs populations independently of their marker expression and size. Our study discovered that enormous amount of CTCs are existing in the blood of breast cancer patient in a variety of sizes.

Citation Format: Yeon-a Choi, Hyun Ju Han, Ae-Ran Choi, Jeong Dong Lee, Gun Min Kim, Hyung Seok Park, Seho Park, Seung Il Kim, Joohyuk Sohn. Discovery and isolation of enormous number of circulating tumor cells in breast cancer patient’s blood based upon cell attachment property [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 3793. doi:10.1158/1538-7445.AM2017-3793

  • ©2017 American Association for Cancer Research.
Previous
Back to top
Cancer Research: 77 (13 Supplement)
July 2017
Volume 77, Issue 13 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 3793: Discovery and isolation of enormous number of circulating tumor cells in breast cancer patient’s blood based upon cell attachment property
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract 3793: Discovery and isolation of enormous number of circulating tumor cells in breast cancer patient’s blood based upon cell attachment property
Yeon-a Choi, Hyun Ju Han, Ae-Ran Choi, Jeong Dong Lee, Gun Min Kim, Hyung Seok Park, Seho Park, Seung Il Kim and Joohyuk Sohn
Cancer Res July 1 2017 (77) (13 Supplement) 3793; DOI: 10.1158/1538-7445.AM2017-3793

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 3793: Discovery and isolation of enormous number of circulating tumor cells in breast cancer patient’s blood based upon cell attachment property
Yeon-a Choi, Hyun Ju Han, Ae-Ran Choi, Jeong Dong Lee, Gun Min Kim, Hyung Seok Park, Seho Park, Seung Il Kim and Joohyuk Sohn
Cancer Res July 1 2017 (77) (13 Supplement) 3793; DOI: 10.1158/1538-7445.AM2017-3793
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Clinical Research (Excluding Clinical Trials)

  • Abstract LB-250: Liquid biopsy in NSCLC: EpCAM+ and EpCAM- circulating tumor cells, tumor derived extracellular vesicles and cell-free circulating tumor DNA
  • Abstract LB-239: Pharmacodynamic changes confirm the mechanism of action mediating SD-101 efficacy, in combination with pembrolizumab, in a phase 1b/2 study in metastatic melanoma (MEL-01)
  • Abstract LB-249: Examination of analytical factors impacting concordance of plasma-tumor testing by next-generation sequencing (NGS)
Show more 3

Poster Presentations - Proffered Abstracts

  • Abstract LB-236: Risk of tMDS/AML after chemotherapy for first primary lymphoid malignancy, 2000-2013
  • Abstract LB-001: Impact of direct physician engagement with racial/ethnic minorities for oncology clinical trial access and accrual model
  • Abstract LB-107: EV-TRACK: transparent reporting and centralizing knowledge of extracellular vesicles to support the validation of extracellular vesicle biomarkers in cancer research
Show more 3

Poster Presentations - Liquid Biopsies 3: Circulating Tumor Cells, Extracellular Vesicles, and Exosomes

  • Abstract 3795: Dynamic acquisition of HER2 expression on circulating tumor cells in gastric cancer patients correlates to developing therapeutic resistance
  • Abstract 3798: Multiplex phenotyping of circulating cancer associated macrophage-like cells in patients with solid tumors
  • Abstract 3778: PD-L1 expression on circulating tumor cells and its comparison with tumor tissues in Japanese lung cancer patients
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement